Viatris (VTRS) Short term Debt (2019 - 2026)
Viatris (VTRS) posted Short term Debt of $1.7 billion for Q2 2026, down 9.95% on a QoQ basis from $1.9 billion in Q1 2026, and up 3.46% year-over-year from $1.7 billion in Q2 2025.
Analysis
Viatris (VTRS) Short term Debt (2019 - 2026) Analysis & Trends
Viatris has reported Short term Debt for 8 years, with the latest figure at $1.7 billion in Q2 2026.
- On a quarterly basis, Short term Debt rose 3.46% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 3.46% increase from a year earlier, with the FY2025 full-year figure at $1.9 billion, up 23192.77% from the prior year.
- Short term Debt was $1.7 billion for Q2 2026 at Viatris, down from $1.9 billion in the prior quarter.
- The five-year high for Short term Debt was $2.6 billion in Q1 2022, with the low at $8.3 million in Q4 2024.
- Average Short term Debt over 5 years is $1.4 billion, with a median of $1.6 billion recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Short term Debt slumped 99.57% in 2024, then jumped 23192.77% in 2025.
- Over 5 years, Short term Debt stood at $1.3 billion in 2022, then surged by 54.35% to $1.9 billion in 2023, then plunged by 99.57% to $8.3 million in 2024, then surged by 23192.77% to $1.9 billion in 2025, then retreated by 10.06% to $1.7 billion in 2026.
- The last three Short term Debt figures came in at $1.7 billion (Q2 2026), $1.9 billion (Q1 2026), and $1.9 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 Bn |
| Mar 31, 2026 | 1.93 Bn |
| Dec 31, 2025 | 1.93 Bn |
| Sep 30, 2025 | 1.95 Bn |
| Jun 30, 2025 | 1.68 Bn |
| Mar 31, 2025 | 8.50 Mn |
| Dec 31, 2024 | 8.30 Mn |
| Sep 30, 2024 | 1.45 Bn |
| Jun 30, 2024 | 2.37 Bn |
| Mar 31, 2024 | 1.90 Bn |
| Dec 31, 2023 | 1.94 Bn |
| Sep 30, 2023 | 1.31 Bn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 508.70 Mn |
| Dec 31, 2022 | 1.26 Bn |
| Sep 30, 2022 | 763.80 Mn |
| Jun 30, 2022 | 1.02 Bn |
| Mar 31, 2022 | 2.61 Bn |
| Dec 31, 2021 | 1.88 Bn |
| Sep 30, 2021 | 1.91 Bn |